Microtech Medical
Microtech Medical is a Hangzhou-based, publicly listed medical device company that develops and sells CGM sensors, a tubeless patch insulin pump, and blood glucose meters for diabetes patients, healthcare providers, and prosumers across Asia, Europe, and the Americas.
- Company typePrivate
- Founded2011
- HeadquartersHangzhou, China
- Headcount501–1,000
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Microtech Medical does
Microtech Medical (微泰医疗) is a Hangzhou-based medical device company founded in 2011 that designs, manufactures, and commercializes hardware for diabetes management. Its portfolio spans three integrated pillars: continuous glucose monitoring (AiDEX CGM, LinX CGM sensors), insulin delivery (Equil tubeless patch insulin pump), and blood glucose monitoring (Exactive BGM family, POCT HbA1c/CRP analyzer), with a developer-facing AiDEX API and a Pancares data management platform. LinX has obtained both China NMPA approval and the CE mark, and an upcoming Closed Loop Artificial Pancreas product targets automated insulin delivery. The company is publicly listed on the Hong Kong Stock Exchange (SEHK:2235).
The company's revenue model is built on hardware sales of devices plus recurring consumables (CGM sensors, infusion sets, test strips). Distribution is multi-channel: direct website sales, regional e-commerce storefronts (Amazon Spain/Italy, Shopee, Lazada, AliExpress), and a growing network of international distributors — notably Tranz Pharma Holdings for Sri Lanka, with product training and exhibition presence in Europe and the Americas (MEDICA, WHX Miami). Customers span Type 1 and Type 2 diabetes patients, healthcare providers, and — increasingly — athletes and health-conscious consumers using CGM for metabolic optimization.
Microtech Medical has raised approximately $173M cumulatively across six funding rounds (2016-2020) from IDG Capital, Qiming Venture Partners, Lilly Asia Ventures, CICC Jiacheng, and others, before its public listing. The company employs 501-1,000 people and operates from its headquarters in Hangzhou Future Sci-Tech City. Leadership is anchored by founder Pan Zheng (Chairman & CEO) and co-founder Dore Mark (Technology). Reported financials show a roughly 4x multi-year revenue trajectory with EBITDA inflecting to positive in 2025, alongside active patent filing in US and European patent offices for CGM and wearable glucose monitoring technology.
Microtech Medical firmographics
Firmographics- Name
- Microtech Medical
- Legal name
- MicroTech Medical (Hangzhou) Co., Ltd.
- Website
- https://microtechmd.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Microtech Medical is a Hangzhou-based, publicly listed medical device company that develops and sells CGM sensors, a tubeless patch insulin pump, and blood glucose meters for diabetes patients, healthcare providers, and prosumers across Asia, Europe, and the Americas.
- Ownership category
- akta.pro rank
Microtech Medical industry classification
Industry- Product category
- Diabetes Management Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Continuous Glucose Monitoring (CGM) Systems (HLAHAHAA)
- akta.pro secondary industries
- Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ), Blood Glucose Monitoring (BGM) Meters & Test Strips (HLAHAHAG), Diabetes Care Device Accessories & Adhesives (Sensors/Pump Supplies) (HLAHAHAL), Insulin Pen Needles, Syringes & Infusion Sets (Consumables) (HLAHAHAE), Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)
Keywords
Where Microtech Medical is headquartered
LocationHeadquarters
- HQ city
- Hangzhou
- HQ country
- China
- HQ region
- Asia
Offices1 record
Markets served
Microtech Medical business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- CGM Systems and Sensors: Sale of continuous glucose monitoring systems and disposable sensors. Products include AiDEX CGM System and LinX CGM System Sensor. Revenue is generated from both initial device sales and recurring sensor purchases.
- Insulin Pump Systems: Sale of Equil Patch Insulin Pump systems and associated consumables (infusion sets, reservoirs). The tubeless design provides differentiation in the insulin pump market.
- Blood Glucose Monitoring Systems: Sale of blood glucose meters and test strips. Multiple product lines including Exactive Pro, Exactive Easy, Exactive EQ Simple, Exactive EQ Impulse, Exactive Vital, Insight Connect, and GoChek2 Connect.
- POCT Analyzer Systems: Point-of-care testing devices for HbA1c, CRP, and microalbumin testing, targeting healthcare providers and clinics.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Microtech Medical product offering
Product offeringCore offering
Microtech Medical develops, manufactures, and sells integrated diabetes management medical devices. Its core product portfolio includes continuous glucose monitoring (CGM) systems (AiDEX and LinX sensors), a tubeless patch insulin pump (Equil), a family of blood glucose meters (Exactive line), and a point-of-care testing (POCT) analyzer for HbA1c, CRP, and microalbumin. Revenue is generated through hardware sales of devices and recurring consumables (sensors, infusion sets, test strips), distributed via direct e-commerce, international distributors, and clinical channels across Asia, Europe, and the Americas.
Product overview
Microtech Medical offers an integrated diabetes management portfolio centered on three core pillars: continuous glucose monitoring (CGM), insulin delivery, and blood glucose monitoring. The main products are: (1) Equil™ Patch Insulin Pump - a tubeless patch pump for continuous insulin delivery; (2) AiDEX™ CGM System and LinX CGM System Sensor - wearable devices providing real-time glucose monitoring with 15-day sensor life; (3) A family of Exactive™ blood glucose meters including EQ Simple, Easy, EQ Impulse, Vital, Pro (multi-analyte: glucose/ketone/uric acid), and connected models (Insight Connect, GoChek2 Connect with Bluetooth); (4) POCT Analyzer System for point-of-care testing of HbA1c, CRP, and MAU; (5) Closed Loop Artificial Pancreas - an upcoming automated insulin delivery system; and (6) AiDEX API for developer access to CGM data. The portfolio is designed to address the full spectrum of diabetes management from monitoring to therapy delivery.
Differentiator
Problem solved
Functional benefit
Brands
- Equil: Equil Patch Insulin Pump System - tubeless insulin pump for continuous insulin delivery
- AiDEX
- LinX
- Exactive
- Pancares
- AiDEX API
Quantifiable outcome
- 15-day sensor life (LinX CGM)
- +3 more outcomes
Companies that use Microtech Medical
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Microtech Medical technology and API
TechnologyAPI detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature4 records
Microtech Medical partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered regional and minor.
- Tranz Pharma HoldingsregionalTranz Pharma Holdings in Sri Lanka launched the Continuous Glucose Monitoring System (CGMS) called 'AIDEX X', produced by Microtech Medical in China. This partnership extends Microtech's distribution reach into the South Asian market through a local pharmaceutical distribution partner.
- Andon HealthminorBoth Micro Tech Medical (Hangzhou) and Andon Health are identified as Chinese assignees actively expanding into Western IP jurisdictions, filing patents in US and European patent offices for wearable glucose monitoring technology.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Microtech Medical competitors and assessment
Company assessmentDirect peers
- Dexcom: Global CGM leader with G6/G7 systems. Compares directly to Microtech's AiDEX and LinX CGM lines on the same core product category targeting diabetes patients with real-time glucose monitoring.
- Abbott Diabetes Care: Maker of FreeStyle Libre family of CGMs, the global CGM volume leader. Directly comparable to Microtech's factory-calibrated LinX CGM in disposable sensor form factor and 14-15 day wear time.
- Medtronic Diabetes: Vertically integrated diabetes care company offering CGM (Guardian), insulin pumps (MiniMed), and closed-loop systems (780G). Closest comparable to Microtech's integrated CGM + Equil pump + nascent closed-loop strategy.
- Insulet Corporation: Maker of Omnipod tubeless patch insulin pump, the most direct competitor to Microtech's Equil Patch Insulin Pump in the tubeless CSII segment.
- Tandem Diabetes Care: Specialist insulin pump company with t:slim X2 and Control-IQ automated insulin delivery. Comparable to Microtech's insulin pump and emerging closed-loop artificial pancreas roadmap.
- Ypsomed: European-based diabetes care company with mylife Loop insulin pump and CGM partnerships. Comparable to Microtech's pump business and European footprint via CE Mark.
- Sinocare Inc. Chinese-listed diabetes care company focused on BGM meters and test strips, with growing CGM presence. Closest comparable domestic Chinese peer across the same BGM and diabetes devices categories.
Emerging players
- Andon Health: Chinese medical device manufacturer with CGM and connected BGM products. Comparable to Microtech as a fellow Chinese challenger expanding into Western IP markets and overlapping BGM/CGM lines.
- Senseonics Holdings: Developer of the Eversense implantable long-term CGM system. Comparable to Microtech as a CGM-focused player pursuing differentiated long-wear sensor technology against Dexcom/Abbott incumbents.
Broad incumbents
- Roche Diabetes Care: Major diabetes care incumbent with Accu-Chek BGM and insulin pump systems. Comparable to Microtech's BGM meter portfolio (Exactive, GoChek, Insight Connect) and broader diabetes franchise.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Microtech Medical social profiles
Digital presenceMicrotech Medical compliance and trust
Trust signalCompliance4 records
Microtech Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Microtech Medical leadership team
Management profileNumber of profiles
Profiles2 records
Microtech Medical funding detail
Funding detailFunding overview
Funding rounds6 records
Investors17 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Microtech Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Microtech Medical
What does Microtech Medical do?
Microtech Medical develops, manufactures, and sells integrated diabetes management medical devices. Its core product portfolio includes continuous glucose monitoring (CGM) systems (AiDEX and LinX sensors), a tubeless patch insulin pump (Equil), a family of blood glucose meters (Exactive line), and a point-of-care testing (POCT) analyzer for HbA1c, CRP, and microalbumin. Revenue is generated through hardware sales of devices and recurring consumables (sensors, infusion sets, test strips), distributed via direct e-commerce, international distributors, and clinical channels across Asia, Europe, and the Americas.
Is Microtech Medical a public or private company?
Microtech Medical is a private company. It is classified as public and is currently operating.
When was Microtech Medical founded?
Microtech Medical was founded in 2011. It employs 501 to 1,000 people.
Where is Microtech Medical based?
Microtech Medical is headquartered in Hangzhou, China, in the Asia region.
How does Microtech Medical make money?
Four revenue lines are on record. CGM Systems and Sensors are the primary driver. The others are insulin Pump Systems, blood Glucose Monitoring Systems and POCT Analyzer Systems.
Who are Microtech Medical's main competitors?
Direct peers on record are Dexcom, Abbott Diabetes Care, Medtronic Diabetes, Insulet Corporation, Tandem Diabetes Care, Ypsomed and Sinocare Inc.. Emerging players are Andon Health and Senseonics Holdings. Roche Diabetes Care is listed as a broad incumbent.
Does Microtech Medical have an API?
Yes. AiDEX API platform for developers to access and integrate Microtech Medical's CGM data. Available at https://aidexapi.microtechmd.com/home. No additional technical specifications (REST/GraphQL, auth method, rate limits, versioning, sandbox) are provided in the source material. Developer documentation is at aidexapi.microtechmd.com/home.
What industry is Microtech Medical in?
Microtech Medical's product category is Diabetes Management Medical Devices. Its primary akta.pro industry code is HLAHAHAA, Continuous Glucose Monitoring (CGM) Systems, with a secondary code of HLAHAHAJ, Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators). Its NAICS code is 334510 and its SIC code is 3845.